MNPR - Monopar to Present Data at today's Connective Tissue Oncology Society (CTOS) Annual Meeting

2023-11-01 09:18:55 ET

DENVER, Colo., Nov 1, 2023 ( www.247marketnews.com )- Monopar Therapeutics Inc (NASDAQ: MNPR) stated, this morning, that it’s presenting data, from its ongoing Phase 1b open-label, dose-escalating clinical trial of camsirubicin in patients with advanced soft tissue sarcoma (ASTS) later today at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting. Monopar’s poster presentation can be found at the following link: https://www.monopartx.com/pipeline/Camsirubicin/mnpr-201-001-clinical-trial .

Monopar Therapeutics is trading at $0.628, up $0.179 (+39.78%), on 6.57M premarket shares traded.

Its 52-week range is $0.395 to $4.88. Its next key resistance point is 69-cents and this morning’s premarket high of 74-cents; if it can break through those, on strong volume, during the regular session, it may run above 90-cents.

24/7 MARKET NEWS, INC …

The post Monopar to Present Data at today’s Connective Tissue Oncology Society (CTOS) Annual Meeting appeared first on 24/7 Market News .

For further details see: